Deerfield Management Company »

Fulgent Genetics shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Fulgent Genetics (FLGT) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Fulgent Genetics

Tip: Access up to 7 years of quarterly data

All positions including Fulgent Genetics held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulgent Genetics by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $284k 9.8k 28.91

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Fulgent Genetics

Dimensional Fund Advisors
Vanguard Group
Wells Fargo & Company
Millennium Management
Park West Asset Management
Citadel Advisors
Jpmorgan Chase & Co
Charles Schwab Investment Management
Norges Bank Investment Management
Point72 Asset Management
Susquehanna International
Bank of New York Mellon
Divisadero Street Capital Management
Jane Street
TCW Group

View all funds holding Fulgent Genetics